Market Opens

Kathleen Bock, Managing Director and Head of Vanguard Investments Canada Inc. (“Vanguard”), and her team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to close the market to celebrate Vanguard’s 50th anniversary globally. On May 1st, 2025, Vanguard celebrates its 50th anniversary in global business and extends their deepest gratitude to their clients, partners (called "Crew"), for your continued support of its mission to take a stand for all investors. With 14 years in the Canadian market, Vanguard is one of the largest investment management companies in the world, managing $10 Trillion (CAD $13.8 Trillion) in assets. Canadians hold $123B (CAD) in Vanguard assets and benefit from its stability and experience, low-cost investing solutions, and client focus. Vanguard has offices in the United States, Canada, Mexico, Europe, and Australia. Vanguard offers 440 funds to its more than 50 million investors worldwide.

Stephanie Wolfe, Executive Vice President, Head of Marketing, Global X Investments Canada Inc. (“Global X”), and her team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (TSX), to open the market to celebrate the launch of their eight new ETFs: Global X Enhanced Equal Weight Canadian Telecommunications Covered Call ETF (TSX: RNCL), Global X Enhanced Gold Producer Equity Covered Call ETF (TSX: GLCL), Global X Equal Weight Canadian REITs Index ETF (TSX: REIT), Global X Equal Weight Canadian Telecommunications Covered Call ETF (TSX: RNCC), Global X Equal Weight U.S. Banks Index ETF (TSX: UBNK), Global X Equal Weight U.S. Groceries & Staples Index ETF (TSX: UMRT), Global X Defence Tech Index ETF (TSX: SHLD), Global X Equal Weight Global Healthcare Index ETF (TSX: MEDX). Global X is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Global X product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Global X has approximately $35 billion of assets under management and 142 ETFs listed on major Canadian stock exchanges. Global X is a wholly owned subsidiary of the Mirae Asset Financial Group, which manages approximately $900 billion of assets across 19 countries and global markets around the world.

Meaghan Stovel McKnight, Chief Executive Officer, Make-A-Wish Canada (“Make-A-Wish”) and her team, joined Rob Peterman, Chief Commercial Officer, Toronto Stock Exchange (“TSX”), to open the market to celebrate Make-A-Wish’s milestone of 40,000 wishes granted in Canada since 1983, and mark the end of World Wish Month. April is World Wish Month™, and Make-A-Wish® Canada is celebrating 40,000 wishes granted over the past 40 years—2,011 of them in 2024 alone. Make-A-Wish creates life-changing wishes that are essential to the treatment journey for children with critical illnesses, helping them build the strength they need to fight. As part of Make-A-Wish® International, we are the world’s leading wish-granting organization, serving children in every community in Canada and in over 50 countries. Make-A-Wish Canada has been recognized as a Great Place to Work® for the second year in a row, and was also named one of the Best Workplaces™ Led by Women in 2025 and one of the Top 100 Best Workplaces for Giving Back in 2024.

Peter van der Velden, Managing General Partner, Lumira Ventures (“Lumira”) and Michael Mazza, Executive Director, Terry Fox Foundation, and their teams, joined Omar Khafagy, Head, Client Success, Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), to close the market to celebrate the launch of The Cancer Breakthrough Fund, a bold new partnership committed to accelerating innovation and commercialization driven by ground-breaking research. Lumira Ventures is a leading North American life sciences venture capital firm with a long and deep track record of building transformative companies that impact patients globally, while generating strong returns for investors. In the past six quarters, Lumira has participated in $1.4B of financings, added 8 new companies to its portfolio, enjoyed 5 exits / realizations, and its portfolio companies have received 5 FDA approvals for novel therapies. Lumira is actively raising the Cancer Breakthrough Fund, in partnership with the Terry Fox Foundation, in parallel with its core fund, Lumira Ventures Fund V. The Cancer Breakthrough Fund will invest in companies led by mission-driven entrepreneurs focused on the goal of delivering novel therapies to patients in the fight against cancer. The Terry Fox Foundation honours the vision and spirit of an iconic Canadian while raising critical funds for cancer research. As a leading national charitable organization, the Terry Fox Foundation plays a vital role in building community, funding innovative cancer research projects, and bringing hope and health to millions of Canadians. Together, the two organizations are combining capital, expertise, and vision to bring new hope and solutions to cancer patients worldwide.